SCHEMBL19797355

SCHEMBL19797355

CC1(C)c2ccccc2N(c2ccc(P(=O)(c3ccc(N4c5ccccc5C(C)(C)c5ccccc54)cc3)c3ccccn3)cc2)c2ccccc21

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGLN1 Q9GZT9 4/20 0.34
▸ GRM1 Q13255 1/20 0.33
▸ LMNA P02545 3/20 0.33
▸ GAA P10253 2/20 0.33
▸ KMT2A Q03164 3/20 0.33
▸ HTT P42858 2/20 0.33
▸ MEN1 O00255 2/20 0.33
▸ MAPT P10636 2/20 0.33
▸ THRB P10828 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ RECQL P46063 1/20 0.33
▸ CYP1A2 P05177 2/20 0.32
▸ CYP2D6 P10635 2/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ CYP3A4 P08684 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32
▸ CYP2C19 P33261 1/20 0.32
▸ THPO P40225 1/20 0.32
▸ CA1 P00915 1/20 0.32
▸ CA2 P00918 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19797414 0.88 ITGB2 (0.33) EGLN1LMNAGAAKMT2AHTT
SCHEMBL19797405 0.83 FAAH (0.33) EGLN1HTTALDH1A1PGR
SCHEMBL19797356 0.83 ALDH1A1 (0.42) EGLN1LMNAKMT2AHTTMEN1
SCHEMBL19797382 0.83 ALDH1A1 (0.31) ALDH1A1NPSR1
SCHEMBL13231589 0.82 LMNA (0.39) LMNAGAAKMT2AHTTMEN1
SCHEMBL19797360 0.82 EGLN1 (0.33) EGLN1LMNAKMT2AHTTMEN1
SCHEMBL19797352 0.80 EGLN1 (0.33) EGLN1LMNAKMT2AHTTMEN1
SCHEMBL19797359 0.80 LMNA (0.40) EGLN1LMNAGAAKMT2AHTT
SCHEMBL19797377 0.79 NPSR1 (0.31) NPSR1
SCHEMBL19797354 0.79 LMNA (0.40) EGLN1LMNAGAAKMT2AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10388889-B2 Substituted phosphines as components of organic light-emitting devices SAMSUNG DISPLAY CO., LTD. (KR) 2019-08-20 — — US disclosed
US-20180026206-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2018-01-25 — — US disclosed
US-20180026206-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2018-01-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180026206-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CYP1A1, CYP1B1 EGLN1 2290/4885GRM1 1113/4885LMNA 2798/4885
US-10388889-B2 Substituted phosphines as components of organic light-emitting devices CRY1, CRY2, PER2 EGLN1 4390/4885GRM1 84/4885LMNA 3701/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback